$ACHV
ACHIEVE LIFE SCIENCES, INC.

2022 Q3 Form 10-Q Financial Statement

#000156459022029122 Filed on August 11, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.770M $2.866M $2.838M
YoY Change 31.78% 38.12% 21.28%
% of Gross Profit
Research & Development $9.869M $7.207M $4.388M
YoY Change 114.96% -21.89% -22.23%
% of Gross Profit
Depreciation & Amortization $55.00K $56.00K $60.00K
YoY Change -9.84% -16.42% 0.0%
% of Gross Profit
Operating Expenses $9.869M $7.207M $7.226M
YoY Change 47.45% -21.89% 28.08%
Operating Profit
YoY Change
Interest Expense $481.0K $404.0K $357.0K
YoY Change 15933.33% 13366.67% 3470.0%
% of Operating Profit
Other Income/Expense, Net -$438.0K -$395.0K $6.000K
YoY Change 43700.0% 4288.89% -140.0%
Pretax Income -$13.08M -$10.47M -$7.573M
YoY Change 95.44% -7.45% -5.34%
Income Tax
% Of Pretax Income
Net Earnings -$13.08M -$10.47M -$7.573M
YoY Change 95.44% -7.45% -5.33%
Net Earnings / Revenue
Basic Earnings Per Share -$1.35 -$1.08 -$0.80
Diluted Earnings Per Share -$1.35 -$1.08 -$800.6K
COMMON SHARES
Basic Shares Outstanding 9.682M 9.648M 9.459M
Diluted Shares Outstanding 9.694M 9.648M 9.459M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.20M $29.38M $36.34M
YoY Change -45.37% -30.05% 22.76%
Cash & Equivalents $18.20M $29.40M $36.30M
Short-Term Investments
Other Short-Term Assets $2.615M $1.457M $1.355M
YoY Change 105.91% 238.84% 69.38%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $20.96M $31.15M $37.69M
YoY Change -39.66% -26.59% 23.83%
LONG-TERM ASSETS
Property, Plant & Equipment $18.00K $33.00K $49.00K
YoY Change -82.0% 22.22% 48.48%
Goodwill $1.034M $1.034M $1.034M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $239.0K $240.0K $253.0K
YoY Change 1.7% 5.73% 26.5%
Total Long-Term Assets $2.766M $2.837M $2.922M
YoY Change -9.78% -9.48% -10.4%
TOTAL ASSETS
Total Short-Term Assets $20.96M $31.15M $37.69M
Total Long-Term Assets $2.766M $2.837M $2.922M
Total Assets $23.72M $33.99M $40.61M
YoY Change -37.24% -25.41% 20.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $412.0K $656.0K $418.0K
YoY Change -49.45% 14.09% -30.33%
Accrued Expenses $6.504M $4.703M $3.592M
YoY Change 187.66% 14.85% 23.86%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.916M $5.359M $4.010M
YoY Change 124.84% 14.75% 14.57%
LONG-TERM LIABILITIES
Long-Term Debt $15.76M $15.46M $15.17M
YoY Change
Other Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Total Long-Term Liabilities $15.76M $15.46M $15.17M
YoY Change 68434.78% 37607.32% 15071.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.916M $5.359M $4.010M
Total Long-Term Liabilities $15.76M $15.46M $15.17M
Total Liabilities $22.68M $20.82M $19.18M
YoY Change 631.82% 341.92% 436.68%
SHAREHOLDERS EQUITY
Retained Earnings -$124.7M -$111.6M -$101.2M
YoY Change 44.33% 40.03%
Common Stock $125.7M $124.8M
YoY Change 3.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.044M $13.17M $21.43M
YoY Change
Total Liabilities & Shareholders Equity $23.72M $33.99M $40.61M
YoY Change -37.24% -25.41% 20.52%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$13.08M -$10.47M -$7.573M
YoY Change 95.44% -7.45% -5.33%
Depreciation, Depletion And Amortization $55.00K $56.00K $60.00K
YoY Change -9.84% -16.42% 0.0%
Cash From Operating Activities -$11.31M -$8.320M -$6.800M
YoY Change 30.06% -8.35% 5.39%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 126.0K 1.361M 95.00K
YoY Change 1475.0% -93.65% -59.75%
NET CHANGE
Cash From Operating Activities -11.31M -8.320M -6.800M
Cash From Investing Activities
Cash From Financing Activities 126.0K 1.361M 95.00K
Net Change In Cash -11.18M -6.959M -6.685M
YoY Change 28.72% -156.32% 7.55%
FREE CASH FLOW
Cash From Operating Activities -$11.31M -$8.320M -$6.800M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M18D
CY2022Q1 achv Shares Issued On Exercise Of Warrants Value
SharesIssuedOnExerciseOfWarrantsValue
24000
CY2022Q1 achv Adjustments To Additional Paid In Capital Shares Issued Through At The Market Offering
AdjustmentsToAdditionalPaidInCapitalSharesIssuedThroughAtTheMarketOffering
91000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
99000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-185000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
165000
achv Increase Decrease In Accrued Clinical Liabilities
IncreaseDecreaseInAccruedClinicalLiabilities
1694000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-837000
achv Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
1000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15099000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
24000
achv Proceeds From At Market Offering
ProceedsFromAtMarketOffering
1499000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
20000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
47000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1456000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21674000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13644000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6148000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
43072000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
28042000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
823000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
26000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
18.57
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0997
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0997
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0997
CY2022Q2 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
0
achv Indemnification Expense
IndemnificationExpense
0
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-7573000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
21433000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
840000
CY2022Q2 achv Adjustments To Additional Paid In Capital Shares Issued Through At The Market Offering
AdjustmentsToAdditionalPaidInCapitalSharesIssuedThroughAtTheMarketOffering
1408000
CY2022Q2 achv Stock Issued During Period Value Restricted Stock Unit Settlement Withheld And Retired To Treasury
StockIssuedDuringPeriodValueRestrictedStockUnitSettlementWithheldAndRetiredToTreasury
-47000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-10468000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
13166000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
37286000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
542000
CY2021Q1 achv Shares Issued On Exercise Of Warrants Value
SharesIssuedOnExerciseOfWarrantsValue
236000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
23000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-7999000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
30088000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
621000
CY2021Q2 achv Shares Issued On Exercise Of Warrants Value
SharesIssuedOnExerciseOfWarrantsValue
95000
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
18000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-11311000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
40854000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-111600000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29400000
CY2022Q2 achv Working Capital Balance
WorkingCapitalBalance
25800000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15100000
CY2015Q2 us-gaap Finite Lived Intangible Assets Fair Value Disclosure
FiniteLivedIntangibleAssetsFairValueDisclosure
3100000
CY2015Q2 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P14Y
us-gaap Operating Lease Payments
OperatingLeasePayments
29000
us-gaap Operating Lease Payments
OperatingLeasePayments
53000
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y6M29D
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y6M29D
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y6M29D
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y6M29D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0997
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
111000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
223000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
223000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000
CY2022Q2 achv Finite Lived Intangible Assets Amortization Expense After Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearTwo
973000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1530000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
522090
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
26.11
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
27983000
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
27983000
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
50000
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
50000
achv Maximum Maturity Period Of Cash And Cash Equivalents
MaximumMaturityPeriodOfCashAndCashEquivalents
P90D
CY2022Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
15000000
CY2022Q2 us-gaap Convertible Debt
ConvertibleDebt
15460000
CY2022Q2 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
16074000
CY2021Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
15000000
CY2021Q4 us-gaap Convertible Debt
ConvertibleDebt
14920000
CY2021Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
15204000
CY2021Q4 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0225
CY2021Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.070
CY2022Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
15000000
CY2021Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
15000000
CY2022Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
100000
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
109000
CY2022Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
560000
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
29000
CY2022Q2 us-gaap Convertible Debt
ConvertibleDebt
15460000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2022Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
26625
us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
26625
CY2021Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2021Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
0
us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
300450
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.83
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
25
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
28522.56
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
822515
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0165
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0061
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.2280
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
840000
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
621000
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
4300000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2315337
CY2022Q2 us-gaap Contractual Obligation
ContractualObligation
39000
CY2022Q2 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
39000
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
33000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y11M26D
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
35903000
us-gaap Operating Lease Expense
OperatingLeaseExpense
66000
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
100000
us-gaap Operating Lease Expense
OperatingLeaseExpense
100000
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
16000
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
15000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.0983
us-gaap Share Based Compensation
ShareBasedCompensation
1663000
us-gaap Share Based Compensation
ShareBasedCompensation
1163000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1775401

Files In Submission

Name View Source Status
0001564590-22-029122-index-headers.html Edgar Link pending
0001564590-22-029122-index.html Edgar Link pending
0001564590-22-029122.txt Edgar Link pending
0001564590-22-029122-xbrl.zip Edgar Link pending
achv-10q_20220630.htm Edgar Link pending
achv-20220630.xsd Edgar Link pending
achv-ex311_7.htm Edgar Link pending
achv-ex321_6.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g4iegmpx3mfa000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
achv-20220630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
achv-20220630_lab.xml Edgar Link unprocessable
achv-20220630_pre.xml Edgar Link unprocessable
achv-10q_20220630_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
achv-20220630_cal.xml Edgar Link unprocessable